| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4648627
Max Phase: Preclinical
Molecular Formula: C28H23BBrF3NO3P
Molecular Weight: 520.28
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: O=C(CC[P+](c1ccc(F)cc1)(c1ccc(F)cc1)c1ccc(F)cc1)Nc1ccc2c(c1)B(O)OC2.[Br-]
Standard InChI: InChI=1S/C28H22BF3NO3P.BrH/c30-20-2-9-24(10-3-20)37(25-11-4-21(31)5-12-25,26-13-6-22(32)7-14-26)16-15-28(34)33-23-8-1-19-18-36-29(35)27(19)17-23;/h1-14,17,35H,15-16,18H2;1H
Standard InChI Key: HBKWJDIPCIWMNK-UHFFFAOYSA-N
Associated Targets(Human)
WiDr 1835 Activities
MIA PaCa-2 5949 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
MCF7 126967 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
4T1 1737 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 520.28 | Molecular Weight (Monoisotopic): 520.1455 | AlogP: | #Rotatable Bonds: |
| Polar Surface Area: | Molecular Species: | HBA: | HBD: |
| #RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
| Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
References
| 1. Jonnalagadda SK, Wielenberg K, Ronayne CT, Jonnalagadda S, Kiprof P, Jonnalagadda SC, Mereddy VR.. (2020) Synthesis and biological evaluation of arylphosphonium-benzoxaborole conjugates as novel anticancer agents., 30 (14): [PMID:32527557] [10.1016/j.bmcl.2020.127259] |
Source
Source(1):